Objectives: This study is aimed to investigate the outcome of one-stage ureteroscopy (URS) and percutaneous nephrolithotomy (PCNL) for simultaneous ureteral and renal stones over 10years at a tertiary urology institute.
Materials And Methods: We retrospectively analyzed the data of patients who were operated on for simultaneous ureteral and renal stones from January 2011 to December 2020. Patients were divided into 2 groups: group A, who underwent one-stage URS and prone PCNL, and group B, who underwent staged procedures. The overall success, complications, operative time, and hospital stays were compared between the 2 groups.
Results: Data for 190 patients were reviewed; mean age was 50 ± 13years old, and 146 (77%) were male. The one-stage (A) and staged (B) groups included 102 and 88 patients, respectively. Group A included older patients, with a high The American Society of Anesthesiologists score, while group B included more patients with multiple or staghorn stones. The one-stage group recorded shorter operative time (120 ± 12min vs. 140 ± 16min, = 0.02) and shorter hospital stays (3days [2-6] vs. 4days [3-9], = 0.06). Otherwise, both groups had equal outcomes in terms of success rates and complications.
Conclusions: PCNL and URS can be performed in one-session for simultaneous ureteral and renal stones, except for multiple renal and staghorn stones. The results are comparable to those of the staged procedure in terms of success rate and complications, with the advantage of a shorter operative time and hospital stay.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132179 | PMC |
http://dx.doi.org/10.1097/CU9.0000000000000087 | DOI Listing |
J Clin Med
November 2024
Department of Gynecology and Gynecologic Oncology, Medical University of Białystok, 15-276 Białystok, Poland.
: In endometriosis, urinary tract involvement occurs in 1-5.5% of cases, where the ureter is affected in 9-23%. Unfortunately, endometriosis may remain asymptomatic even with significant anatomical progression.
View Article and Find Full Text PDFJ Fluoresc
November 2024
Kawaguchi Municipal Medical Center, 180, Nishiaraijuku, Kawaguchi City, Saitama, 333-0833, Japan.
Ureters can be visualized on a monitor via fluorescence observation technology and an near-infrared (NIR) fluorescent ureteral catheter (NIRFUC). Eureka, an artificial intelligence (AI) platform, can be used to analyze surgical videos and highlight nerves and loose connective tissue (LCT) in the dissection layer. In this study, we aimed to evaluate the feasibility of using simultaneous NIRFUC and AI assistance for anatomical recognition during laparoscopic surgery.
View Article and Find Full Text PDFCase Rep Oncol
November 2024
Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Sci Rep
November 2024
Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
There are few analyses comparing complete nephrectomy with resection of the renal parenchyma only (CN) or radical nephrectomy that includes simultaneous resection of the parenchyma, affected perirenal fascia, perirenal fat, and ureter (RN) relative to partial nephrectomy (PN) for patients with nonmetastatic (M0) renal cell carcinoma (RCC) in terms of overall survival (OS). This study aimed to evaluate the effect of different nephrectomy on the OS of M0 RCC and to identify the main beneficiaries of different nephrectomy. The data was collected from the Surveillance, Epidemiology and End Results (SEER) database.
View Article and Find Full Text PDFBMC Urol
November 2024
Department of Urology, Pediatric Urology and Andrology, Justus-Liebig University of Giessen, Giessen, Germany.
Purpose: Robotic surgery is increasingly utilized in the treatment of urothelial carcinoma of the upper urinary tract (UTUC). This study investigates the advantages and burden of robot-assisted surgical treatment of the urothelial carcinoma of the upper urinary tract in a referral urological department, along with their functional and oncological results.
Methods: The study included 66 prospectively enrolled patients who were surgically treated by a single, robotically specialized surgeon between July 2019 and December 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!